2-Methyl-5-naphthalen-1-yl-[1,3,4]oxadiazole

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-Methyl-5-naphthalen-1-yl-[1,3,4]oxadiazole
• 英文别名: 2-Methyl-5-naphthalen-1-yl-1,3,4-oxadiazole
• 化学式: C₁₃H₁₀N₂O
• 分子量: 210.235
• InChiKey: QGJSVYJAUDIHMI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  38.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  Naphthalene-1-carboxylic acid N'-acetyl-hydrazide 在 三氯氧磷 作用下， 以84%的产率得到2-Methyl-5-naphthalen-1-yl-[1,3,4]oxadiazole
  参考文献：
  名称：

  Synthesis and spectral properties of 2-methyl-5-aryl-1,3,4-oxadiazoles

  摘要：

  DOI：

  10.1007/bf02291805

文献信息

• [EN] NOVEL SMALL MOLECULE SHC BLOCKERS FOR TREATING LIVER DISEASE AND METABOLIC DISEASE<br/>[FR] NOUVEAUX BLOQUEURS DE SHC À PETITES MOLÉCULES POUR LE TRAITEMENT D'UNE MALADIE HÉPATIQUE ET D'UNE MALADIE MÉTABOLIQUE
  申请人：BUTO CORP

  公开号：WO2021138450A1

  公开（公告）日：2021-07-08

  The subject matter disclosed herein is directed to novel She inhibitors of Formula (II). These compounds are useful for treating impaired insulin sensitivity, glucose tolerance, obesity, diabetes, metabolic syndrome, NAFLD, NASH, PSC, PBC, or other metabolic syndrome component conditions.

  本文所披露的主题是针对新型化合物Formula (II)的She抑制剂。这些化合物可用于治疗受损的胰岛素敏感性、葡萄糖耐量、肥胖、糖尿病、代谢综合征、非酒精性脂肪肝、非酒精性脂肪性肝炎、原发性胆汁性胆管炎、原发性胆汁性肝炎或其他代谢综合征组分疾病。
• Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Same
  申请人：Kawakami Sachiko

  公开号：US20090153041A1

  公开（公告）日：2009-06-18

  A quinoxaline-based, new bipolar organic compound is provided, and a light emitting element using the quinoxaline-based compound is demonstrated. The quinoxaline derivative of the invention has a structure in which carbon at one or both of the 2-position and the 3-position of the quinoxaline unit are bonded, via an arylene group, with an amine unit which has a substituted or unsubstituted five-membered ring or a substituted or unsubstituted condensed ring containing a five-membered ring structure. The quinoxaline-based compound was proven to possess bipolar characteristics in view of carrier transportation, which allows the fabrication of a light emitting element and an electronic appliance with a low driving voltage and low power consumption.

  本发明提供了一种基于喹喔啉的新型双极有机化合物，并演示了使用该基于喹喔啉的化合物的发光元件。该发明的喹喔啉衍生物具有结构，在其中，喹喔啉单元的2位和/或3位的碳通过芳基烃基团与一种含有取代或未取代的五元环或含有五元环结构的取代或未取代的缩合环的胺单元键合。基于喹喔啉的化合物被证明具有双极特性，具有载流子传输的特性，这允许制造具有低驱动电压和低功耗的发光元件和电子设备。
• Quinoxaline derivative, and light emitting element, licht emitting device and electronic appliance using the same
  申请人：SEMICONDUCTOR ENERGY LABORATORY CO., LTD.

  公开号：EP2067778A1

  公开（公告）日：2009-06-10

  A quinoxaline-based, new bipolar organic compound is provided, and a light emitting element using the quinoxaline-based compound is demonstrated. The quinoxaline derivative of the invention has a structure in which carbon at one or both of the 2-position and the 3-position of the quinoxaline unit are bonded, via an arylene group, with an amine unit which has a substituted or unsubstituted five-membered ring or a substituted or unsubstituted condensed ring containing a five-membered ring structure. The quinoxaline-based compound was proven to possess bipolar characteristics in view of carrier transportation, which allows the fabrication of a light emitting element and an electronic appliance with a low driving voltage and low power consumption.

  本发明提供了一种基于喹喔啉的新型双极有机化合物，并展示了一种使用该基于喹喔啉的化合物的发光元件。本发明的喹喔啉衍生物具有这样的结构：喹喔啉单元 2 位和 3 位中的一个或两个位置上的碳通过芳烯基与具有取代或未取代五元环或含有五元环结构的取代或未取代缩合环的胺单元键合。这种基于喹喔啉的化合物被证明在载流子传输方面具有双极特性，因此可以制造低驱动电压和低功耗的发光元件和电子设备。
• Quinoxaline derivative, and light emitting element, light emitting device and electronic appliance using the same
  申请人：Semiconductor Energy Laboratory Co., Ltd.

  公开号：EP2067778B1

  公开（公告）日：2016-08-17
• US8216696B2
  申请人：——

  公开号：US8216696B2

  公开（公告）日：2012-07-10